VIM and breast cancer: Additionally, studies with further IHC and molecular analyses have demonstrated that vimentin, the epidermal growth factor receptor (EGFR), CPK5/6, and CK14 are highly expressed in ER-low-positive or negative BC and less expressed in ER-high-positive BC [5].